Rhoen Klinikum AGHAM:RHK -2.40%74 3-Year Revenue Growth Rate is 5.60% as of Mar. 2026, which is 51% above its 10-year median of 3.70. GuruFocus rates HAM:RHK with a GF Score™ of 74/100 and a GF Value™ of €13.48 (Fairly Valued). The stock has 3 warning signs investors should review. Among 613 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks worse than 54.65% on this metric.
During the past 12 months, Rhoen Klinikum AG's average Revenue per Share Growth Rate was 3.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 4.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 4.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Rhoen Klinikum AG was 16.20% per year. The lowest was -15.40% per year. And the median was 3.70% per year.
Rhoen Klinikum AG (HAM:RHK) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Rhoen Klinikum AG 3-Year Revenue Growth Rate Related Terms
HAM:RHK vs HCA, THC, DVA: 3-Year Revenue Growth Rate Comparison
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG 3-Year Revenue Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's 3-Year Revenue Growth Rate falls into.
Rhoen Klinikum AG 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 5.60% mean?
Rhoen Klinikum AG (HAM:RHK) has a 3-Year Revenue Growth Rate of 5.60% as of Mar. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Rhoen Klinikum AG and its competitors. This is 51% above median its historical median of 3.70. According to the industry distribution chart, Rhoen Klinikum AG ranks #335 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 54.6%.
Is Rhoen Klinikum AG's 3-Year Revenue Growth Rate too high?
Rhoen Klinikum AG's current 3-Year Revenue Growth Rate of 5.60% is 51% above median its 10-year median of 3.70. The Healthcare Providers & Services industry median 3-Year Revenue Growth Rate is 6.90. Rhoen Klinikum AG's value of 5.60% is 18.8% below this industry median. Based on the distribution chart, Rhoen Klinikum AG ranks #335 out of 613 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Rhoen Klinikum AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's 3-Year Revenue Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #335 out of 613 companies for 3-Year Revenue Growth Rate. This places Rhoen Klinikum AG in the lower half of its industry. The industry median 3-Year Revenue Growth Rate is 6.90. Rhoen Klinikum AG's value of 5.60% is 18.8% below this benchmark. While the company's 10-year median is 3.70 vs. the industry median of 6.90, Rhoen Klinikum AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Revenue Growth Rate among Healthcare Providers & Services companies is 6.90, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current 3-Year Revenue Growth Rate of 5.60% is 18.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Revenue Growth Rate is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current 3-Year Revenue Growth Rate is 5.60%, which is 51% above median its own 10-year median of 3.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Based on GuruFocus' analysis, Rhoen Klinikum AG (HAM:RHK) is currently considered Fairly Valued. The stock's GF Value™ is €13.48, compared to a current price of €12.20 — trading 9.5% below its estimated fair value. The current 3-Year Revenue Growth Rate is 5.60%, which is 51% above median its 10-year median of 3.70 and 18.8% below the Healthcare Providers & Services industry median of 6.90. Rhoen Klinikum AG's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Rhoen Klinikum AG (HAM:RHK), the current 3-Year Revenue Growth Rate is 5.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (HAM:RHK) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued.
The current stock price of €12.20 is trading 9.5% below its estimated GF Value™ of €13.48.
GuruFocus considers Rhoen Klinikum AG to be Fairly Valued.
Key valuation signals for HAM:RHK:
3-Year Revenue Growth Rate: 5.60% (51% above median its 10-year median of 3.70)
GF Value™: €13.48 vs. price of €12.20 (9.5% below fair value)
Industry Position: 18.8% below the Healthcare Providers & Services median (#335 of 613)
No single metric tells the full story. See the HAM:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score
Get the complete analysis for HAM:RHK
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:RHK has been successfully added to your 